BIOGEN INC. Pre-tax Income 2007-2026 | BIIB
Beta
What is BIOGEN INC.'s current pre-tax income?
BIOGEN INC. (BIIB) annual pre-tax income for 2025 was $1.56B, a 18.34% decline from 2024. BIOGEN INC. pre-tax income for the quarter ending March 31, 2026 was $377.7M.
What was BIOGEN INC.'s pre-tax income in 2024?
BIOGEN INC. annual pre-tax income for 2024 was $1.91B, a 46.98% increase from 2023.
What was BIOGEN INC.'s pre-tax income in 2023?
BIOGEN INC. annual pre-tax income for 2023 was $1.30B, a 63.90% decline from 2022.
What is BIOGEN INC.'s 5-year pre-tax income CAGR?
BIOGEN INC. pre-tax income grew at a compound annual growth rate (CAGR) of 20.97% from FY2020 to FY2025, going from $5.05B to $1.56B over 5 years.
Pre-tax Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-21.0%
FY2020
$5.05B
→
FY2025
$1.56B
07080910111213141516171819202122232425
5 years selected
Pre-tax Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.56B | -18.3% | 10-K |
| FY2024 | $1.91B | +47.0% | 10-K |
| FY2023 | $1.30B | -63.9% | 10-K |
| FY2022 | $3.59B | +105.8% | 10-K |
| FY2021 | $1.75B | -65.4% | 10-K |
| FY2020 | $5.05B | -29.2% | 10-K |
| FY2019 | $7.13B | +20.8% | 10-K |
| FY2018 | $5.90B | +15.0% | 10-K |
| FY2017 | $5.13B | +4.0% | 10-K |
| FY2016 | $4.93B | +3.5% | 10-K |
| FY2015 | $4.77B | +20.8% | 10-K |
| FY2014 | $3.95B | +59.1% | 10-K |
| FY2013 | $2.48B | +33.7% | 10-K |
| FY2012 | $1.86B | +8.4% | 10-K |
| FY2011 | $1.71B | +39.1% | 10-K |
| FY2010 | $1.23B | -7.7% | 10-K |
| FY2009 | $1.33B | +15.3% | 10-K |
| FY2008 | $1.16B | +35.6% | 10-K |
| FY2007 | $852.2M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →